Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.
Culine S, Théodore C, Bekradda M, Farhat F, Terrier-Lacombe MJ, Droz JP. Culine S, et al. Among authors: farhat f. Am J Clin Oncol. 1997 Apr;20(2):184-8. doi: 10.1097/00000421-199704000-00017. Am J Clin Oncol. 1997. PMID: 9124197 Clinical Trial.
Sequential vinorelbine-capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial.
Ghosn M, Kattan J, Farhat F, Younes F, Nasr F, Moukadem W, Gasmi J, Chahine G; Cancer Research Group/Collaborative Group (CRG/CG), Beirut-Lebanon. Ghosn M, et al. Among authors: farhat f. Cancer Chemother Pharmacol. 2008 Jun;62(1):11-8. doi: 10.1007/s00280-007-0565-x. Epub 2007 Aug 24. Cancer Chemother Pharmacol. 2008. PMID: 17717668 Clinical Trial.
311 results